cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.4329638.v1
title: Supplementary Material for: Association between Obstructive Sleep Apnea and Acute Kidney Injury in Critically Ill Patients: A Propensity-Matched Study

description: <b><i>Background/Aims:</i></b> Obstructive sleep apnea (OSA) is a known risk factor for chronic kidney disease (CKD); however, its association with acute kidney injury (AKI) is not well documented. We aimed to study whether OSA is associated with the risk of AKI in the intensive care unit (ICU) setting. <b><i>Methods:</i></b> All consecutive adult Olmsted County, MN residents who were admitted in Mayo Clinic ICUs from January 1, 2010 to December 31, 2010 were screened. Chronic and acute risk factors were collected within the first 48 h of ICU admission. Logistic regression and propensity score matching were used to examine crude and adjusted associations of OSA with AKI. <b><i>Results:</i></b> Among 1,259 enrolled ICU patients, 183 patients had a diagnosis of OSA prior to the index ICU admission. Compared with non-OSA patients, the incidence of AKI in OSA patients was more frequent (41 vs. 57%, <i>p </i>&lt; 0.001). In univariate analysis, it was found that CKD, age, gender, Caucasian race, congestive heart failure, cerebrovascular disease, diabetes mellitus, body mass index, and OSA were associated with AKI. In the multivariate model, following adjustment for age, gender, race, and chronic and acute risk factors, OSA was found to have an independent association with AKI (OR 1.53; 95% CI 1.04-2.24; <i>p </i>= 0.031). Among 176 propensity score matched pairs, there was a significant difference in the incidence of AKI between the OSA and non-OSA groups (OR 1.54; 95% CI 1.01-2.35; <i>p</i> = 0.04). <b><i>Conclusions:</i></b> The history of OSA diagnosed by polysomnography is associated with higher risk of AKI in critically ill patients.
DOI: 10.5281/zenodo.3791586
title: WWV Centennial Festival of Frequency Measurement 5 MHz Collected Data

description: Manually consolidated 5MHz data from the Festival of Frequency Measurement. Instructions posted here: https://hamsci.org/wwv-centennial-festival-frequency-measurements Callsigns of participants who posted data to Zenodo: VK3ZAZ, WX4US, N7IVV, K7KMQ, AG7PQ, KM4YMI, N1IRO, AC6SL, W1KU, N1NAZ, W6OQI, VE3OAT, NA0B, VE3YX, KE0ARE, XE3I, WB4HIR, W6BM, AA6LK, W6MSU, K0ANS, W3FAY, KA6WKE, WV5L, VE7CNF, N7XZ, K2LYV, VE6IXD, K7JKM, K4BSE, N2MD, VE6GRT, WA5FRF, VA3ROM, KG4ARN, N8OBJ, NU0C, W8UM, AA8K Callsigns of participants whose data was not uploaded to Zenodo: AJ4YA, N9MVO, W8EDU, N7QNM, W9INE, WA7BNM ___________________________________________________________________ <strong>Version 2: </strong> <em>Formatting changes:</em> The data has been reformatted to use callsigns, rather than Zenodo IDs, as the primary identifiers for datasets. Data is included as .csv files, an Excel workbook and a .mat file for processing in MATLAB. <br> <em>Errata:</em> Latitude and longitude were corrected for the following stations: VA3ROM, VK3ZAZ, VE6IXD, VE3OAT, AC6SL, VE7CNF, K4BSE, VE6GRT. Added precision to some others.<br> WA7BNM used a GPSDO, which was not listed in the original dataset; this has been corrected. _____________________________________________________________________
DOI: 10.6084/m9.figshare.4327940
title: Supplementary Material for: Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause

description: <b><i>Background/Aims:</i></b> The renal prognosis of post-renal acute kidney injury (PoR-AKI) has not been verified so far. The objective of this study was to assess the association of baseline anemia with long-term renal prognosis in patients with PoR-AKI. <b><i>Methods:</i></b> We performed a multicenter retrospective cohort study. Consecutive adult patients from December 2006 to February 2010, who met the requirements as mentioned in the definition of PoR-AKI, were included. Patients without data on baseline renal function and at 6 months after PoR-AKI were excluded. We set baseline hemoglobin (Hb) level (g/dl) as the main exposure to be tested. The main outcome measure was long-term renal prognosis as determined by the difference between proximate estimated glomerular filtration rate (eGFR) at 6 months after diagnosis of PoR-AKI and baseline eGFR prior to the occurrence of the present PoR-AKI (ΔeGFR after 6 months) using the general linear model. <b><i>Results:</i></b> We included 136 patients with PoR-AKI. The most frequent cause of PoR-AKI was malignancy, accounting for 39.0% (n = 53) of cases. Multivariate analysis adjusted for possible confounders showed that ΔeGFR after 6 months significantly changed by -4.28 ml/min/1.73 m<sup>2</sup> for every 1 g/dl lower Hb at diagnosis (95% CI 1.86-6.69, p &lt; 0.01). An additional multivariate analysis that was stratified by the presence or absence of malignancy as the cause of PoR-AKI yielded the same significant result only in the stratum of the nonmalignant cause of PoR-AKI. <b><i>Conclusion:</i></b> Patients with a nonmalignant cause of PoR-AKI who have baseline anemia may have poor long-term renal prognosis. In these cases, close observation of renal function after renal recovery may be required.
DOI: 10.6084/m9.figshare.4327940.v1
title: Supplementary Material for: Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause

description: <b><i>Background/Aims:</i></b> The renal prognosis of post-renal acute kidney injury (PoR-AKI) has not been verified so far. The objective of this study was to assess the association of baseline anemia with long-term renal prognosis in patients with PoR-AKI. <b><i>Methods:</i></b> We performed a multicenter retrospective cohort study. Consecutive adult patients from December 2006 to February 2010, who met the requirements as mentioned in the definition of PoR-AKI, were included. Patients without data on baseline renal function and at 6 months after PoR-AKI were excluded. We set baseline hemoglobin (Hb) level (g/dl) as the main exposure to be tested. The main outcome measure was long-term renal prognosis as determined by the difference between proximate estimated glomerular filtration rate (eGFR) at 6 months after diagnosis of PoR-AKI and baseline eGFR prior to the occurrence of the present PoR-AKI (ΔeGFR after 6 months) using the general linear model. <b><i>Results:</i></b> We included 136 patients with PoR-AKI. The most frequent cause of PoR-AKI was malignancy, accounting for 39.0% (n = 53) of cases. Multivariate analysis adjusted for possible confounders showed that ΔeGFR after 6 months significantly changed by -4.28 ml/min/1.73 m<sup>2</sup> for every 1 g/dl lower Hb at diagnosis (95% CI 1.86-6.69, p &lt; 0.01). An additional multivariate analysis that was stratified by the presence or absence of malignancy as the cause of PoR-AKI yielded the same significant result only in the stratum of the nonmalignant cause of PoR-AKI. <b><i>Conclusion:</i></b> Patients with a nonmalignant cause of PoR-AKI who have baseline anemia may have poor long-term renal prognosis. In these cases, close observation of renal function after renal recovery may be required.
DOI: 10.5285/ad2a4fa0-7b66-4ec5-a5cf-d78944716ec4
title: Geochemical and petrological data pertaining to the eruptive deposits of 1883 caldera-forming eruption of Krakatau

description: Geochemical data has been collected on samples from new exposures of the 1883 deposits, revealed by the 2018 tsunamigenic flank collapse of Anak Krakatau, which provides improved stratigraphic context. Whole-rock data taken by X-ray Florescence shows no systematic stratigraphic correlation. Chemical data for transects across, and spot points on, plagioclase phenocrysts, including some trace element data, all obtained using Electron Probe Microanalysis (EPMA), with Backscatter electron (BSE) images of crystals, obtained using Scanning Electron Microscope, reveal complex zoning profiles. However, chemical data for transects across pyroxene phenocrysts, obtained using EPMA, show this phenocryst phase is largely unzoned. The dataset also includes chemical data for spots on Fe/Ti oxides, included on the rims of pyroxene, and obtained using EPMA. Matrix glass chemistry, obtained via EPMA, shows that the early eruptive ash is more evolved than the pyroclastic material that follows, and that there is a slight overall trend to a more homogenous, less evolved melt composition.
The 1883 eruption of Krakatau was a large, cardera-forming eruption that caused approximately 36,000 fatalities. It is also the only eruption of its size to have accompanying written accounts.
DOI: 10.6084/m9.figshare.4326440
title: Supplementary Material for: Classification of Tattoo Complications in a Hospital Material of 493 Adverse Events

description: <b><i>Background/Aims:</i></b> Tattooing is a global trend. Clinical knowledge of complications is based on case reports collected over a century. Larger cohorts reflecting complications associated with contemporary trends are lacking. <b><i>Methods:</i></b> The study was a retrospective review of a consecutive cohort of patients with tattoo complications diagnosed in the “Tattoo Clinic“ of Bispebjerg University Hospital in Copenhagen, Denmark, from 2008 to 2015, based on patient history and systematic clinical examination. <b><i>Results:</i></b> A total of 493 tattoo complications in 405 patients were studied. Overall, 184 (37%) presented allergic reactions with plaque elevation in 32.2%, excessive hyperkeratosis in 3.7%, and ulceration in 1.4%, predominantly observed in red tattoos and nuances of red; 66 (13%) presented papulo-nodular reactions, mainly observed in black tattoos (considered non-allergic) and due to pigment agglomeration; 53 (11%) had bacterial infections; 46 (9%) were psycho-social complications; 144 (30%) belonged to several specific diagnostic entities, including photosensitivity, pain syndrome, and lymphopathy. We found no cases of cutaneous or other malignancies. Sarcoidosis was primarily seen in black tattoos and was a common associated disease, found in 23 reactions (5%), compared to the background population. <b><i>Conclusion:</i></b> The study introduces a new concept of classification of tattoo complications based on simple tools such as patient history and objective findings supplemented with histology. The study reflects complications originating from presently used tattoo inks, often with organic pigments. The introduced classification has been submitted to the World Health Organisation (WHO) as a proposal to the 11th revision of the International Classification of Diseases.
DOI: 10.6084/m9.figshare.4325804
title: Chest fat quantification via CT based on standardized anatomy space in adult lung transplant candidates

description: The file includes the major discovery and key data and parameters found in the manuscript, such as fat (SAT & VAT) area and attenuation histogram information on single optimal chest CT slice and single slices at the L5 vertebral level and mid-thigh level for all subjects (in this study) in three groups, IPF, COPD and the other as the 3rd group.
DOI: 10.6084/m9.figshare.4325804.v1
title: Chest fat quantification via CT based on standardized anatomy space in adult lung transplant candidates

description: The file includes the major discovery and key data and parameters found in the manuscript, such as fat (SAT & VAT) area and attenuation histogram information on single optimal chest CT slice and single slices at the L5 vertebral level and mid-thigh level for all subjects (in this study) in three groups, IPF, COPD and the other as the 3rd group.
DOI: 10.5517/ccdc.csd.cc2538vf
title: CCDC 1999154: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2538wg
title: CCDC 1999155: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2538xh
title: CCDC 1999156: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2538yj
title: CCDC 1999157: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2538zk
title: CCDC 1999158: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25390m
title: CCDC 1999159: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25391n
title: CCDC 1999160: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25392p
title: CCDC 1999161: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25393q
title: CCDC 1999162: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25394r
title: CCDC 1999163: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25395s
title: CCDC 1999164: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25396t
title: CCDC 1999165: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25397v
title: CCDC 1999166: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25398w
title: CCDC 1999167: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc25399x
title: CCDC 1999168: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539by
title: CCDC 1999169: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539cz
title: CCDC 1999170: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539d0
title: CCDC 1999171: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539f1
title: CCDC 1999172: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539g2
title: CCDC 1999173: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539h3
title: CCDC 1999174: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.5517/ccdc.csd.cc2539j4
title: CCDC 1999175: Experimental Crystal Structure Determination

description: Related Article: Rebecca Scatena, Fabio Montisci, Arianna Lanza, Nicola P. M. Casati, Piero Macchi|2020|Inorg.Chem.|59|10091|doi:10.1021/acs.inorgchem.0c01229
DOI: 10.17632/jwc4rr6kwr.3
title: le Roux et al 2020_PNAS_Animal body size distribution influences the ratios of nutrients supplied to plants

description: This data accompanies the following manuscript: le Roux et al 2020 PNAS Animal body size distribution influences the ratios of nutrients supplied to plants All relevant information is contained within this manuscript. https://www.pnas.org/content/early/2020/08/19/2003269117
DOI: 10.5281/zenodo.4013255
title: DATASET OF "Impact of short-acting vs. standard anaesthetic agents on obstructive sleep apnoea: a randomised, controlled, triple-blind trial"

description: Sleep apnoea is associated with negative outcomes following general anaesthesia. Current recommendations suggest using short-acting anaesthetic agents in preference to standard agents to reduce this risk, but there is currently no evidence to support this. This randomised controlled triple-blind trial tested the hypothesis that a combination of short-acting agents (desflurane-remifentanil) would reduce the postoperative impact of general anaesthesia on sleep apnoea severity compared with standard agents (sevoflurane-fentanyl). Sixty patients undergoing hip arthroplasty under general anaesthesia were randomised to anaesthesia with desflurane-remifentanil or sevoflurane-fentanyl. Respiratory polygraphy was performed before surgery and on the first and third postoperative nights. The primary outcome was the supine apnoea-hypopnoea index on the first postoperative night. Secondary outcomes were the supine apnoea-hypopnoea index on the third postoperative night, and the oxygen desaturation index on the first and third postoperative nights. Additional outcomes included intravenous morphine equivalent consumption and pain scores on postoperative days 1, 2 and 3. Pre-operative sleep study data were similar between groups. Mean (95%CI) values for the supine apnoea-hypopnoea index on the first postoperative night were 18.9 (12.7–25.0) and 21.4 (14.2–28.7) events.h<sup>-1</sup>, respectively, in the short-acting and standard anaesthesia groups (p=0.64). Corresponding values on the third postoperative night were 28.1 (15.8–40.3) and 38.0 (18.3–57.6) events.h<sup>-1</sup> (p=0.34). Secondary sleep- and pain-related outcomes were generally similar in the two groups. In conclusion, short-acting anaesthetic agents did not reduce the impact of general anaesthesia on sleep apnoea severity compared with standard agents. These data should prompt an update of current recommendations.
DOI: 10.5281/zenodo.4013274
title: DATASET OF "Intrathecal morphine and sleep apnoea severity in patients undergoing hip arthroplasty: a randomised, controlled, triple- blinded trial"

description: <strong>Background: </strong>Intrathecal morphine prolongs analgesia after surgery, but has been implicated in postoperative respiratory depression or apnoeic episodes. However, this has not been investigated in a prospective trial using respiratory polygraphy. This randomized controlled triple-blinded trial tested the hypothesis that intrathecal morphine increases sleep apnoea severity, measured using respiratory polygraphy. <strong>Methods: </strong>Sixty patients undergoing hip arthroplasty under spinal anaesthesia received either 15 mg isobaric bupivacaine 0.5% with 0.5 mL normal saline 0.9% (control group) or 15 mg isobaric bupivacaine 0.5% with 0.5 mL intrathecal morphine 100 µg (intrathecal morphine group). Respiratory polygraphy was performed before surgery and on the first and third postoperative nights. The primary outcome was the apnoea-hypopnoea index in the supine position (supine AHI) on the first postoperative night. Secondary outcomes included supine AHI on the third postoperative night, oxygen desaturation index (ODI) and respiratory rate in the first and third postoperative nights. <strong>Results: </strong>On the first postoperative night, mean (95% confidence interval) values for supine AHI were 20.6 (13.9–27.3) and 21.2 (12.4–30.0) events/h in the control and intrathecal morphine groups, respectively (p=0.90). There were no significant between-group differences for any of the secondary outcomes, except for a significantly higher central and mixed apnoea index preoperatively and significantly lower mean SpO<sub>2</sub> on the third postoperative night in the control group. <strong>Conclusions: </strong>Intrathecal morphine did not increase sleep apnoea severity, when measured using respiratory polygraphy. Of note, all patients had an increased number of apnoeic episodes on the third postoperative night.
DOI: 10.14457/tu.the.2019.332
title: ประเด็นปัจจัยทางการตลาดที่ส่งผลต่อการเลือกใช้บริการธนาคารพาณิชย์ของลูกค้ารายใหญ่ในกรุงเทพมหานคร

description: งานวิจัยนี้มีวัตถุประสงค์เพื่อศึกษาประเด็นปัจจัยทางการตลาดที่ส่งผลต่อการเลือกใช้บริการธนาคารพาณิชย์ของลูกค้ารายใหญ่ในกรุงเทพมหานคร ซึ่งการศึกษานี้วิเคราะห์ข้อมูลที่ได้จากการสัมภาษณ์เชิงลึก (In-depth interview) กับลูกค้ารายใหญ่ของธนาคารพาณิชย์แห่งหนึ่งซึ่งมีสถานะเป็นลูกค้ารายใหญ่ของธนาคารพาณิชย์อื่นในกรุงเทพมหานครจำนวน 15 ราย ผลการศึกษาพบว่า ลูกค้ารายใหญ่ให้ความสำคัญในเรื่องผลิตภัณฑ์การลงทุนที่มีความเสี่ยงต่ำและผลิตภัณฑ์ที่มีระยะเวลาการลงทุนสั้น ปัจจัยด้านการส่งเสริมการขาย ลูกค้ามีความต้องการให้สิทธิประโยชน์ตรงกับไลฟ์สไตล์ของตน การเอาใจใส่ที่ดีจากพนักงานและการให้ความช่วยเหลือลูกค้าเมื่อพบปัญหา ความสะดวกในการเดินทาง เช่น ใกล้บ้านและที่ทำงาน หรือมีบริการสาขาในห้างสรรพสินค้า การได้รับบริการอย่างรวดเร็วและถูกต้อง การมีที่จอดรถเพียงพอ และมีห้องรับรองพิเศษไว้บริการ หากธนาคารพาณิชย์สามารถนำประเด็นเหล่านี้ไปปรับปรุงเพื่อตอบสนองความต้องการได้ จะทำให้เกิดประโยชน์แก่ธนาคารในด้านธุรกิจจากกลุ่มลูกค้ารายใหญ่นี้